Skip to main content

Action Mechanisms of Traditional Medicinal Plants used to Control Type 2 Diabetes or Conditions of Metabolic Syndrome, volume II

Cover image for Research Topic "Action Mechanisms of Traditional Medicinal Plants used to Control Type 2 Diabetes or Conditions of Metabolic Syndrome, volume II"
58kviews
Editorial12 September 2023
Editorial: Action mechanisms of traditional medicinal plants used to control type 2 diabetes or conditions of metabolic syndrome, volume II

Metabolic diseases (MD) are a burden for modern societies, they affect individuals’ health as well as public health and the country’s economies. The WHO estimates that most of the world's population lives in countries where overweight and obesity kills more people than underweight. At the same time, diabetes mellitus is now among the top ten global causes of death (WHO, 2023). MD are a cluster of conditions (increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels) that when they occur together are called; Metabolic syndrome and type 2 diabetes; mainly defined by insulin resistance (IR) in the presence of abnormal insulin secretion.

Traditional medicines worldwide are facing a challenge to treat MD that has existed clinically for a long time. However, with the changes in lifestyle (lack of exercise, poor nutrition) and simultaneously increase in life expectancy, these conditions are growing in epidemic proportions and threatening the lives of millions of people. While the life expectancy has increased at an impressive scale, the increase in the average years of a health life lags behind. Although many of the traditional systems have recognized these problems for a long time within specific cultural interpretations of disease states, currently chronic metabolic diseases play an important role in these systems, since healers and primary care providers are an important source of healthcare also for metabolic syndrome and related conditions. At the same time, advances in sciences allow a better understanding and labeling of the diseases that had been previously incorporated in the traditional systems.

The goal of this Research topic was to contribute to understanding how medicinal plants are facing the challenge to treat MD and DM in our “modern” societies. In this aspect seven articles are included in the collection, here with we introduce some of them: Jia and collaborators, demonstrate the effects of Alismatis Rhizoma [Alisma plantago-aquatica subsp. orientale (Sam.) Sam.] on metabolic syndrome with a focus on bioactive triterpenoids using a metabolomic and lipidomic approach. They conclude that Alismatis rhizome, a traditional Chinese medicine, can treat metabolic syndrome mainly by inhibiting energy metabolism, amino acid metabolism, and regulating bile acid to reduce phospholipid content (Jia et al., 2022). Li et al. reported the hypoglycemic effects as well as underlying mechanisms of actions of Chinese polyherbal formula JinQi Jiangtang in the form of oral tablet. From the results of this study, it has been shown that Palmatine, a key active metabolite of JinQi Jiangtang, significantly stimulated the phosphorylation of fibroblast growth factor receptor 1 (FGFR1) and upregulated the glucose transporter 1 (GLUT-1) expression increasing glucose uptake in insulin resistant HepG2 cells and reduced hyperglycemia in high-fat diet-fed streptozotocin-induced diabetic mice. The pharmacological findings of this study have been investigated further using molecular docking, qPCR and western blotting techniques (Li et al., 2022).

The effects of quercetin (a wide distributed flavonoid in the plant kingdom) over Polycystic Ovary Syndrome (PCOS), was reviewed by (Ma et al., 2022). PCOS is a multifactorial endocrine disease, the main clinical features are hyperandrogenemia, ovarian enlargement, no ovulation or oligomenorrhea, accompanied by endocrine abnormalities, metabolic abnormalities, and reproductive dysfunction, the review concludes that quercetin In vitro can relieve oxidative stress and apoptosis of ovarian cells, it also can effectively reduce serum testosterone, luteinizing hormone, the LH/FSH ratio, fasting blood glucose and fasting insulin. The authors recommend for the future the need for more clinical trials applying the flavonoid in PCOS patients.

Ye and coworkers demonstrate that Jiangtang Sanhao formula (JTSHF), a prescription for treating patients with diabetes mellitus (DM) in traditional Chinese medicine may ameliorate skeletal muscle IR in diabetes mice. They claim that its underlying mechanism could be attributed to stimulating the expression and translocation of GLUT4 by activating the AMPKα/SIRT1/PGC-1α signaling pathway(Ye et al., 2022).

Ethnopharmacology in the 21st century faces major challenges solving the needs for improved treatments of Metabolic Syndrome and Type 2 diabetes, we invite you to read the seven works, which will certainly help in better understanding how, traditional systems are dealing with these diseases.

1,397 views

1 citations

ORIGINAL RESEARCH
1 November 2022
Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice
Bingbing Zhu, 6 more and Aili Cao

3,572 views

9 citations

ORIGINAL RESEARCH
9 September 2022
Alismatis Rhizoma methanolic extract—Effects on metabolic syndrome and mechanisms of triterpenoids using a metabolomic and lipidomic approach
Li Jia, 8 more and Miaomiao Jiang

6,490 views

9 citations

ORIGINAL RESEARCH
8 September 2022
Jiangtang Sanhao formula ameliorates skeletal muscle insulin resistance via regulating GLUT4 translocation in diabetic mice
Zimengwei Ye, 10 more and Dongwei Zhang

4,295 views

8 citations

ORIGINAL RESEARCH
25 August 2022
Bailing capsule (Cordyceps sinensis) ameliorates renal triglyceride accumulation through the PPARα pathway in diabetic rats
Qian Zhang, 3 more and Fan Ping
Bailing capsule (Cordyceps sinensis) ameliorates renal triglyceride accumulation through the PPARα pathway in diabetic rats
Diabetic nephropathy (DN) is a severe diabetic complication of the kidney and is the main cause of end-stage kidney disease worldwide. Cordyceps sinensis (C. sinensis) is not only a traditional Chinese medicine (TCM) but also a healthy food. In China, C. sinensis has been widely used to treat various kidney diseases. Bailing Capsule, which active ingredient is C. sinensis, is approved to treat kidney disease, respiratory disease, and immune disease. However, its underlying mechanism in DN remains unclear. The purpose of the present study was to investigate the underlying mechanism of Bailing Capsule on kidney in diabetic rats. The DN model was established by streptozotocin (STZ) injection. Low and high doses of Bailing Capsule were orally administrated for 12 weeks after diabetes induction. Renal function was evaluated by serum creatinine, blood urea nitrogen, 24-h urinary protein, and urinary albumin. Mesangial matrix expansion and renal fibrosis were measured using histopathology staining. We found that the disorder of renal function and pathology in DN rats was significantly modified by Bailing Capsule treatment. Consistently, Bailing Capsule markedly alleviated DN rat glomerulosclerosis, tubulointerstitial injury and renal fibrosis as shown by pathological staining. Moreover, Bailing Capsule significantly reduced the kidney triglyceride content and renal lipid droplet formation in DN rats. The renal transcriptome revealed that Bailing Capsule-treated kidneys had 498 upregulated genes and 448 downregulated genes. These differentially expressed genes were enriched in the peroxisome proliferator activated receptor (PPAR) pathway and fatty acid metabolism function ontology. mRNA and protein expression analyses revealed substantial enhancement of the lipolysis pathway and inhibition of lipogenesis in Bailing Capsule-treated rat kidneys compared to DN rats. Bailing Capsule activated the inhibition expression of PPARα (peroxisome proliferator activated receptor alpha), ACOX1 (acyl-CoA oxidase 1), and SCD (stearoyl-CoA desaturase) in diabetic nephropathy while suppressing the expression of FASN (fatty acid synthase). In conclusion, Bailing Capsule could attenuate renal triglyceride accumulation in diabetic rats by activating moderating PPARα pathway.

8,098 views

37 citations

Astragalus Polysaccharides Alleviate Type 2 Diabetic Rats by Reversing the Expressions of Sweet Taste Receptors and Genes Related to Glycolipid Metabolism in Liver
Sweet taste receptors (STRs) play an important role in glucose metabolism, and type 2 diabetic rats have abnormal expressions of STRs in multiple tissues. Astragalus polysaccharides (APS) has shown a significant therapeutic effect on type 2 diabetes mellitus (T2DM), but its mechanism needs to be further clarified. T2DM rat model was induced by intraperitoneal streptozotocin (STZ) injection and treated with APS for 8 weeks. Using the method of non-targeted metabolomic analysis based on Liquid Chromatography-Mass Spectrometry (LC-MS) to determine the main components of APS powder. Western blotting analysis was used to determine the levels of protein expression, and real-time quantitative PCR analysis was used to detect the levels of gene expression. Gene expression analysis found that APS significantly increased the expressions of signaling molecules in sweet taste receptors (STRs) pathways, including taste receptor family 1 member 2 (T1R2), α-gustducin (Gα) and transient receptor potential cation channel subfamily member 5 (TRPM5), and reversed the expressions of genes related to glucolipid metabolism, including glucose transporters 2 and 4 (GLUT2 and GLUT4), pyruvate carboxylase (PC), fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC) in the liver of T2DM rats. However, APS had no influences on the expressions of genes, including glycogen synthase kinase-3 beta (GSK-3β), pyruvate kinase (PK) and phosphoenolpyruvate carboxykinase (PEPCK) in the liver of T2DM rats. These results suggested that the physiological roles of STRs in the liver were involved in glucose transport and metabolism. The present study revealed that APS alleviated the symptoms of type 2 diabetes mellitus (T2DM) rats, improved HOMA-IR and promoted insulin secretion. APS alleviated T2DM rats by activating the STRs pathway, and promoted glucose transport and lipogenesis.

4,877 views

40 citations

ORIGINAL RESEARCH
22 July 2022
The Hypoglycemic Effect of JinQi Jiangtang Tablets Is Partially Dependent on the Palmatine-Induced Activation of the Fibroblast Growth Factor Receptor 1 Signaling Pathway
Siming Li, 13 more and Wenfei Wang

3,537 views

4 citations